Literature DB >> 31267224

Collagen gel droplet-embedded culture drug sensitivity test (CD-DST) predicts the effect of adjuvant chemotherapy on pancreatic cancer.

Kyohei Ariake1, Fuyuhiko Motoi2, Masamichi Mizuma1, Hideo Ohtsuka1, Hiroki Hayashi1, Kei Nakagawa1, Tatsuo Hata1, Katsutaka Mitachi1, Takeshi Naitoh1, Takashi Kamei1, Michiaki Unno1.   

Abstract

PURPOSE: We evaluated the clinical effectiveness of collagen gel droplet-embedded culture drug sensitivity tests (CD-DSTs) in predicting the efficacy of adjuvant chemo-therapeutic treatments for pancreatic cancer (PC).
METHODS: The clinicopathological characteristics and prognoses of 22 PC patients who underwent CD-DST after pancreatectomy at Tohoku University between 2012 and 2016 were analyzed retrospectively. Eligibility criteria were resectable or borderline resectable PC, successful evaluation for 5-fluorouracil sensitivity by CD-DST, treatment with S-1 adjuvant chemotherapy, and no preoperative chemotherapy.
RESULTS: The rate of successful evaluation by CD-DST was 52.3% in PC. The optimal T/C ratio, defined as the ratio of the number of cancer cells in the treatment group (T) to that in the control group (C), for 5-fluorouracil was 85% using receiver operating characteristic curve analysis. The sensitive group (T/C ratio < 85%; n = 11) had a better recurrence-free survival rate than the resistant group (T/C ratio ≥ 85%; n = 11; P = 0.029). A Cox proportional hazards regression model demonstrated that sensitivity to 5-fluorouracil was an independent predictor of recurrence on multivariate analysis (hazard ratio 3.28; 95.0% CI 1.20-9.84; P = 0.020).
CONCLUSIONS: CD-DSTs helped to predict PC recurrence after S-1 adjuvant chemotherapy.

Entities:  

Keywords:  CD-DST; Chemosensitivity test; Pancreatic cancer

Mesh:

Substances:

Year:  2019        PMID: 31267224     DOI: 10.1007/s00595-019-01842-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  17 in total

1.  Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST).

Authors:  Masafumi Kawamura; Masatoshi Gika; Tomohiro Abiko; Yoshimasa Inoue; Takahiko Oyama; Yotaro Izumi; Hisayuki Kobayashi; Koichi Kobayashi
Journal:  Cancer Chemother Pharmacol       Date:  2006-08-08       Impact factor: 3.333

2.  Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively.

Authors:  Kentaro Maejima; Akira Tokunaga; Teruo Kiyama; Hitoshi Kanno; Hideki Bou; Masanori Watanabe; Hideyuki Suzuki; Eiji Uchida
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

3.  Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.

Authors:  Vincent P Groot; Neda Rezaee; Wenchuan Wu; John L Cameron; Elliot K Fishman; Ralph H Hruban; Matthew J Weiss; Lei Zheng; Christopher L Wolfgang; Jin He
Journal:  Ann Surg       Date:  2018-05       Impact factor: 12.969

4.  An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures.

Authors:  H Kobayashi; K Tanisaka; O Doi; K Kodama; M Higashiyama; H Nakagawa; M Miyake; T Taki; S Hara; M Yasutomi; Y Hanatani; K Kotake; T Kubota
Journal:  Int J Oncol       Date:  1997-09       Impact factor: 5.650

Review 5.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

6.  Gene expression analysis for predicting gemcitabine sensitivity in pancreatic cancer patients.

Authors:  Jianfeng Bai; Naohiro Sata; Hideo Nagai
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

7.  Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Sohei Satoi; Hiroki Yamaue; Kentaro Kato; Shinichiro Takahashi; Seiko Hirono; Shin Takeda; Hidetoshi Eguchi; Masayuki Sho; Keita Wada; Hiroyuki Shinchi; A Hon Kwon; Satoshi Hirano; Taira Kinoshita; Akimasa Nakao; Hiroaki Nagano; Yoshiyuki Nakajima; Keiji Sano; Masaru Miyazaki; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-08       Impact factor: 7.027

8.  Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after S-1 with radiation therapy followed by gemcitabine/nab-paclitaxel therapy: a case report.

Authors:  Kyohei Ariake; Fuyuhiko Motoi; Masamichi Mizuma; Keigo Murakami; Tatsuyuki Takadate; Hideo Ohtsuka; Koji Fukase; Kunihiro Masuda; Hiroki Hayashi; Kei Nakagawa; Naoaki Sakata; Takanori Morikawa; Shimpei Maeda; Takeshi Naitoh; Shinichi Egawa; Michiaki Unno
Journal:  Surg Case Rep       Date:  2017-01-18

9.  Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer.

Authors:  C W Michalski; M Erkan; D Sauliunaite; T Giese; R Stratmann; C Sartori; N A Giese; H Friess; J Kleeff
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

10.  Clinical predictive value of in vitro anticancer drug sensitivity test for the therapeutic effect of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

Authors:  Eiji Mekata; Hiromichi Sonoda; Tomoharu Shimizu; Takeshi Tatsuta; Tomohiro Yamaguchi; Yoshihiro Endo; Tohru Tani
Journal:  Mol Clin Oncol       Date:  2013-04-11
View more
  2 in total

1.  Novel candidate factors predicting the effect of S-1 adjuvant chemotherapy of pancreatic cancer.

Authors:  Katsutaka Mitachi; Kyohei Ariake; Hiroki Shima; Satoko Sato; Takayuki Miura; Shimpei Maeda; Masaharu Ishida; Masamichi Mizuma; Hideo Ohtsuka; Takashi Kamei; Kazuhiko Igarashi; Michiaki Unno
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

2.  Effect of oxaliplatin-based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof-of-concept study.

Authors:  A Prabhu; A Brandl; S Wakama; S Sako; H Ishibashi; A Mizumoto; N Takao; M Ichinose; S Motoi; Y Liu; Y Yonemura
Journal:  BJS Open       Date:  2021-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.